{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:56:05Z","timestamp":1792176965584,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2023ZD0500900"],"award-info":[{"award-number":["2023ZD0500900"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171970"],"award-info":[{"award-number":["82171970"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472018"],"award-info":[{"award-number":["82472018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402320"],"award-info":[{"award-number":["82402320"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"crossref","award":["Z221100007422027"],"award-info":[{"award-number":["Z221100007422027"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key Research and Development Program of China","award":["2024YFE0113500"],"award-info":[{"award-number":["2024YFE0113500"]}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["20240484725"],"award-info":[{"award-number":["20240484725"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M750132"],"award-info":[{"award-number":["2024M750132"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2023IR17"],"award-info":[{"award-number":["2023IR17"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2024IR07"],"award-info":[{"award-number":["2024IR07"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2024CX18"],"award-info":[{"award-number":["2024CX18"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2024SF64"],"award-info":[{"award-number":["2024SF64"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00259-025-07441-6","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:23:13Z","timestamp":1752139393000},"page":"647-662","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["ImmunoPET imaging of c-Met using a nanobody-based tracer [68Ga]Ga-NOTA-PFCM01 in pancreatic ductal adenocarcinoma models and non-human primates"],"prefix":"10.1007","volume":"53","author":[{"given":"Xinyao","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lele","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenpeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8729-4547","authenticated-orcid":false,"given":"Lei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"7441_CR1","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.3390\/cancers13112777","volume":"13","author":"MH Uddin","year":"2021","unstructured":"Uddin MH, Al-Hallak MN, Philip PA, Mohammad RM, Viola N, Wagner K-U, et al. Exosomal MicroRNA in pancreatic Cancer diagnosis, prognosis, and treatment: from bench to bedside. Cancers (Basel). 2021;13:2777.","journal-title":"Cancers (Basel)"},{"key":"7441_CR2","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.12998\/wjcc.v9.i13.2969","volume":"9","author":"JH Yoon","year":"2021","unstructured":"Yoon JH, Jung Y-J, Moon S-H. Immunotherapy for pancreatic cancer. World J Clin Cases. 2021;9:2969\u201382.","journal-title":"World J Clin Cases"},{"key":"7441_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.tibs.2003.09.001","volume":"28","author":"A Bertotti","year":"2003","unstructured":"Bertotti A, Comoglio PM. Tyrosine kinase signal specificity: lessons from the HGF receptor. Trends Biochem Sci. 2003;28:527\u201333.","journal-title":"Trends Biochem Sci"},{"issue":"Suppl 2","key":"7441_CR4","first-page":"22","volume":"11","author":"F Galimi","year":"1993","unstructured":"Galimi F, Brizzi MF, Comoglio PM. The hepatocyte growth factor and its receptor. Stem Cells. 1993;11(Suppl 2):22\u201330.","journal-title":"Stem Cells"},{"key":"7441_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13045-019-0759-9","volume":"12","author":"Q Wang","year":"2019","unstructured":"Wang Q, Yang S, Wang K, Sun S-Y. MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer. J Hematol Oncol. 2019;12:63.","journal-title":"J Hematol Oncol"},{"key":"7441_CR6","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1177\/1758834011422556","volume":"3","author":"SL Organ","year":"2011","unstructured":"Organ SL, Tsao M-S. An overview of the c-MET signaling pathway. Ther Adv Med Oncol. 2011;3:S7\u201319.","journal-title":"Ther Adv Med Oncol"},{"key":"7441_CR7","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.ejmech.2017.08.044","volume":"143","author":"PK Parikh","year":"2018","unstructured":"Parikh PK, Ghate MD. Recent advances in the discovery of small molecule c-Met kinase inhibitors. Eur J Med Chem. 2018;143:1103\u201338.","journal-title":"Eur J Med Chem"},{"key":"7441_CR8","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nrm3012","volume":"11","author":"L Trusolino","year":"2010","unstructured":"Trusolino L, Bertotti A, Comoglio PM. MET signalling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol. 2010;11:834\u201348.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7441_CR9","doi-asserted-by":"publisher","first-page":"6737","DOI":"10.1039\/D1BM00674F","volume":"9","author":"D Li","year":"2021","unstructured":"Li D, Yang M, Liang M, Mei C, Lin Y, Yang F, et al. c-Met-targeted near-infrared fluorescent probe for real-time depiction and dissection of perineural invasion and lymph node metastasis lesions in pancreatic ductal adenocarcinoma xenograft models. Biomater Sci. 2021;9:6737\u201352.","journal-title":"Biomater Sci"},{"key":"7441_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.pan.2020.01.003","volume":"20","author":"SP Pothula","year":"2020","unstructured":"Pothula SP, Pirola RC, Wilson JS, Apte MV. Pancreatic stellate cells: aiding and abetting pancreatic cancer progression. Pancreatology. 2020;20:409\u201318.","journal-title":"Pancreatology"},{"key":"7441_CR11","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1093\/carcin\/bgu122","volume":"35","author":"MB Patel","year":"2014","unstructured":"Patel MB, Pothula SP, Xu Z, Lee AK, Goldstein D, Pirola RC, et al. The role of the hepatocyte growth factor\/c-MET pathway in pancreatic stellate cell\u2013endothelial cell interactions: antiangiogenic implications in pancreatic cancer. Carcinogenesis. 2014;35:1891\u2013900.","journal-title":"Carcinogenesis"},{"key":"7441_CR12","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1080\/00498254.2018.1534030","volume":"49","author":"C Yang","year":"2019","unstructured":"Yang C, Zhao X, Sun X, Li J, Wang W, Zhang L, et al. Preclinical pharmacokinetics of a novel anti-c-Met antibody-drug conjugate, SHR-A1403, in rodents and non-human primates. Xenobiotica. 2019;49:1097\u2013105.","journal-title":"Xenobiotica"},{"key":"7441_CR13","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nrclinonc.2017.40","volume":"14","author":"CA Bradley","year":"2017","unstructured":"Bradley CA, Salto-Tellez M, Laurent-Puig P, Bardelli A, Rolfo C, Tabernero J, et al. Targeting c-MET in Gastrointestinal tumours: rationale, opportunities and challenges. Nat Rev Clin Oncol. 2017;14:562\u201376.","journal-title":"Nat Rev Clin Oncol"},{"key":"7441_CR14","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1021\/acs.chemrev.9b00738","volume":"120","author":"W Wei","year":"2020","unstructured":"Wei W, Rosenkrans ZT, Liu J, Huang G, Luo Q-Y, Cai W. ImmunoPET: concept, design, and applications. Chem Rev. 2020;120:3787\u2013851.","journal-title":"Chem Rev"},{"key":"7441_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.7150\/thno.4024","volume":"2","author":"M Fani","year":"2012","unstructured":"Fani M, Maecke HR, Okarvi SM. Radiolabeled peptides: valuable tools for the detection and treatment of Cancer. Theranostics. 2012;2:481\u2013501.","journal-title":"Theranostics"},{"key":"7441_CR16","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s11307-018-1234-7","volume":"21","author":"Y Huo","year":"2019","unstructured":"Huo Y, Kang L, Pang X, Shen H, Yan P, Zhang C, et al. Noninvasive PET imaging of a Ga-68-Radiolabeled RRL-Derived peptide in hepatocarcinoma murine models. Mol Imaging Biol. 2019;21:286\u201396.","journal-title":"Mol Imaging Biol"},{"key":"7441_CR17","doi-asserted-by":"publisher","first-page":"15118","DOI":"10.1021\/acs.jmedchem.4c00759","volume":"67","author":"L Song","year":"2024","unstructured":"Song L, Jiang S, Yang Q, Huang W, Qiu Y, Chen Z, et al. Development of a novel Peptide-Based PET tracer [68Ga]Ga-DOTA-BP1 for BCMA detection in multiple myeloma. J Med Chem. 2024;67:15118\u201330.","journal-title":"J Med Chem"},{"key":"7441_CR18","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1021\/acs.bioconjchem.4c00497","volume":"35","author":"Q Yang","year":"2024","unstructured":"Yang Q, Song L, Chen Z, Qiu Y, Wang T, Sun X, et al. Pharmacokinetic positron emission tomography imaging of an optimized CD38-Targeted 68Ga-Labeled peptide in multiple myeloma: A pilot study. Bioconjug Chem. 2024;35:1985\u201396.","journal-title":"Bioconjug Chem"},{"issue":"5","key":"7441_CR19","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s00259-024-07036-7","volume":"52","author":"W Huang","year":"2025","unstructured":"Huang W, Wang T, Qiu Y, Li C, Chen B, Song L, et al. CD38-specific ImmunoPET imaging for multiple myeloma diagnosis and therapeutic monitoring: preclinical and first-in-human studies. Eur J Nucl Med Mol Imaging. 2025;52(5):1791\u2013804.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"7441_CR20","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1007\/s00259-025-07106-4","volume":"52","author":"W Huang","year":"2025","unstructured":"Huang W, Li L, Zhou Y, Yang Q, Mixdorf JC, Barnhart TE, et al. Preclinical evaluation of zirconium-89 labeled anti-Trop2 antibody-drug conjugate (Trodelvy) for imaging in gastric cancer and triple-negative breast cancer. Eur J Nucl Med Mol Imaging. 2025;52(7):2369\u201383.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7441_CR21","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.2967\/jnumed.111.102293","volume":"53","author":"EM Jagoda","year":"2012","unstructured":"Jagoda EM, Lang L, Bhadrasetty V, Histed S, Williams M, Kramer-Marek G, et al. Immuno-PET of the hepatocyte growth factor receptor Met using the 1-armed antibody onartuzumab. J Nucl Med. 2012;53:1592\u2013600.","journal-title":"J Nucl Med"},{"key":"7441_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jconrel.2021.02.019","volume":"332","author":"M Liang","year":"2021","unstructured":"Liang M, Yang M, Wang F, Wang X, He B, Mei C, et al. Near-infrared fluorescence-guided resection of micrometastases derived from esophageal squamous cell carcinoma using a c-Met-targeted probe in a preclinical xenograft model. J Control Release. 2021;332:171\u201383.","journal-title":"J Control Release"},{"key":"7441_CR23","doi-asserted-by":"publisher","first-page":"188425","DOI":"10.1016\/j.bbcan.2020.188425","volume":"1874","author":"H-P Yao","year":"2020","unstructured":"Yao H-P, Hudson R, Wang M-H. Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer. Biochimica et Biophysica Acta (BBA) - Rev Cancer. 2020;1874:188425.","journal-title":"Biochimica et Biophysica Acta (BBA) - Rev Cancer."},{"key":"7441_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/BF02988521","volume":"17","author":"T Higashi","year":"2003","unstructured":"Higashi T, Saga T, Nakamoto Y, Ishimori T, Fujimoto K, Doi R, et al. Diagnosis of pancreatic cancer using fluorine-18 Fluorodeoxyglucose positron emission tomography (FDG PET) --usefulness and limitations in clinical reality. Ann Nucl Med. 2003;17:261\u201379.","journal-title":"Ann Nucl Med"},{"key":"7441_CR25","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1158\/1078-0432.CCR-14-1051","volume":"21","author":"CJ Whatcott","year":"2015","unstructured":"Whatcott CJ, Diep CH, Jiang P, Watanabe A, LoBello J, Sima C, et al. Desmoplasia in primary tumors and metastatic lesions of pancreatic Cancer. Clin Cancer Res. 2015;21:3561\u20138.","journal-title":"Clin Cancer Res"},{"key":"7441_CR26","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1200\/JCO.2012.47.4189","volume":"31","author":"DR Spigel","year":"2013","unstructured":"Spigel DR, Ervin TJ, Ramlau RA, Daniel DB, Goldschmidt JH, Blumenschein GR, et al. Randomized phase II trial of onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer. J Clin Oncol. 2013;31:4105\u201314.","journal-title":"J Clin Oncol"},{"key":"7441_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.7150\/thno.37098","volume":"10","author":"FE Escorcia","year":"2020","unstructured":"Escorcia FE, Houghton JL, Abdel-Atti D, Pereira PR, Cho A, Gutsche NT, et al. ImmunoPET predicts response to Met-targeted radioligand therapy in models of pancreatic Cancer resistant to Met kinase inhibitors. Theranostics. 2020;10:151\u201365.","journal-title":"Theranostics"},{"key":"7441_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1021\/acs.bioconjchem.4c00019","volume":"35","author":"NY Luo","year":"2024","unstructured":"Luo NY, Minne RL, Gallant JP, Gunaratne GS, West JL, Javeri S, et al. Development of an engineered Single-Domain antibody for targeting MET in Non-Small cell lung Cancer. Bioconjug Chem. 2024;35:389\u201399.","journal-title":"Bioconjug Chem"},{"key":"7441_CR29","doi-asserted-by":"publisher","first-page":"6376","DOI":"10.1021\/acs.molpharmaceut.4c00938","volume":"21","author":"RL Minne","year":"2024","unstructured":"Minne RL, Luo NY, Mork CM, Wopat MR, Esbona K, Javeri S, et al. Evaluation of a novel MET-Targeting Camelid-Derived antibody in head and neck Cancer. Mol Pharm. 2024;21:6376\u201384.","journal-title":"Mol Pharm"},{"key":"7441_CR30","doi-asserted-by":"publisher","first-page":"9331","DOI":"10.1039\/C9SC03840J","volume":"10","author":"H Hong","year":"2019","unstructured":"Hong H, Zhou Z, Zhou K, Liu S, Guo Z, Wu Z. Site-specific C-terminal dinitrophenylation to reconstitute the antibody Fc functions for nanobodies. Chem Sci. 2019;10:9331\u20138.","journal-title":"Chem Sci"},{"key":"7441_CR31","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1007\/s00259-022-05739-3","volume":"49","author":"G Hu","year":"2022","unstructured":"Hu G, Zhu W, Liu Y, Wang Y, Zhang Z, Zhu S, et al. Development and comparison of three 89Zr-labeled anti-CLDN18.2 antibodies to noninvasively evaluate CLDN18.2 expression in gastric cancer: a preclinical study. Eur J Nucl Med Mol Imaging. 2022;49:2634\u201344.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7441_CR32","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/pbi.12094","volume":"11","author":"S De Buck","year":"2013","unstructured":"De Buck S, Nolf J, De Meyer T, Virdi V, De Wilde K, Van Lerberge E, et al. Fusion of an Fc chain to a VHH boosts the accumulation levels in Arabidopsis seeds. Plant Biotechnol J. 2013;11:1006\u201316.","journal-title":"Plant Biotechnol J"},{"key":"7441_CR33","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1073\/pnas.1801524115","volume":"115","author":"JR Ingram","year":"2018","unstructured":"Ingram JR, Blomberg OS, Rashidian M, Ali L, Garforth S, Fedorov E, et al. Anti-CTLA-4 therapy requires an Fc domain for efficacy. Proc Natl Acad Sci U S A. 2018;115:3912\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7441_CR34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1158\/2326-6066.CIR-13-0013","volume":"1","author":"MJ Selby","year":"2013","unstructured":"Selby MJ, Engelhardt JJ, Quigley M, Henning KA, Chen T, Srinivasan M, et al. Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells. Cancer Immunol Res. 2013;1:32\u201342.","journal-title":"Cancer Immunol Res"},{"key":"7441_CR35","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ccell.2018.02.010","volume":"33","author":"F Arce Vargas","year":"2018","unstructured":"Arce Vargas F, Furness AJS, Litchfield K, Joshi K, Rosenthal R, Ghorani E, et al. Fc effector function contributes to the activity of human Anti-CTLA-4 antibodies. Cancer Cell. 2018;33:649\u2013e6634.","journal-title":"Cancer Cell"},{"key":"7441_CR36","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.5c00430","author":"J Kong","year":"2025","unstructured":"Kong J, Zhang H, Tian R, Ge W, He Y, Chen T, et al. Development of [18F]AlF-RESCA-H006 as a novel molecular probe for 5T4 tumor imaging and exploration of its application in pancreatic adenocarcinoma. Mol Pharm. 2025. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5c00430","journal-title":"Mol Pharm"},{"key":"7441_CR37","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s00259-022-05967-7","volume":"50","author":"X Qin","year":"2023","unstructured":"Qin X, Guo X, Liu T, Li L, Zhou N, Ma X, et al. High in-vivo stability in preclinical and first-in-human experiments with [18F]AlF-RESCA-MIRC213: a 18F-labeled nanobody as PET Radiotracer for diagnosis of HER2-positive cancers. Eur J Nucl Med Mol Imaging. 2023;50:302\u201313.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07441-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07441-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07441-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T05:05:44Z","timestamp":1764219944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07441-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["7441"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07441-6","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed and this study was approved by the Animal Committee of Peking University First Hospital (Approval No. BDYY-J2024167 and BDYY-J2024171). No studies with human participants were mentioned (Clinical trial number: not applicable).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The requirement for informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate\u00a0and publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}